Study Details
FIREFLY-1
(IRB#: IRB_00138633)
The description and purpose of the study drug is to research the use of an investigational product labeled NA- IP (DAY 101- formerly TAK-580/MLN2480) to treat Low-Grade Glioma and other advanced solid tumors in pediatric and age-of-majority participants
- All genders
- All Ages
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: All Ages
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?
Yes
IRB#: IRB_00138633
PI: Nicholas Whipple
Department: PEDIATRIC HEMATOLOGY/ONCOLOGY
Approval Date: 2021-08-04 06:00:00
Study Categories: Cancer Studies
Specialties: Pediatric Hematology & Oncology